SPDR DoubleLine Total Return Tactical ETF - COMMON STOCK (TOTL)

CUSIP: 78467V848

Q1 2020 13F Holders as of 31 Mar 2020

Holder snapshot 6 signals
Share change
-5,632,977
SEC-reported price per share
$47.96
Number of holders
316
Value change
-$271,232,925
Number of buys
125
Number of sells
184
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
96,624,650

Security key

78467V848

Report period

Q1 2020

Institutions

316

Top holders

10

Ownership snapshot

Top reported holders of TOTL - SPDR DoubleLine Total Return Tactical ETF - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
316
Shares
44,533,487
Rows available
316
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders
324
Q1 2020 holders
316
Holder diff
-8
Investor Q4 2019 Shares Q1 2020 Shares Share Diff Share Chg % Q4 2019 value Q1 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .